JP2007519654A5 - - Google Patents

Download PDF

Info

Publication number
JP2007519654A5
JP2007519654A5 JP2006550004A JP2006550004A JP2007519654A5 JP 2007519654 A5 JP2007519654 A5 JP 2007519654A5 JP 2006550004 A JP2006550004 A JP 2006550004A JP 2006550004 A JP2006550004 A JP 2006550004A JP 2007519654 A5 JP2007519654 A5 JP 2007519654A5
Authority
JP
Japan
Prior art keywords
ring
het
phenyl
defined above
het ring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006550004A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007519654A (ja
JP4733648B2 (ja
Filing date
Publication date
Priority claimed from DE102004004974A external-priority patent/DE102004004974A1/de
Application filed filed Critical
Publication of JP2007519654A publication Critical patent/JP2007519654A/ja
Publication of JP2007519654A5 publication Critical patent/JP2007519654A5/ja
Application granted granted Critical
Publication of JP4733648B2 publication Critical patent/JP4733648B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006550004A 2004-01-31 2005-01-18 マトリックスメタロプロテイナーゼ阻害剤としての使用のためのチエノ−イミノ酸誘導体 Expired - Fee Related JP4733648B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102004004974A DE102004004974A1 (de) 2004-01-31 2004-01-31 Thieno-Iminosäure-Derivate als Inhibitoren von Matrix-Metalloproteinasen
DE102004004974.2 2004-01-31
PCT/EP2005/000417 WO2005073236A2 (de) 2004-01-31 2005-01-18 Thieno-iminosäure-derivate als inhibitoren von matrix-metalloproteinasen

Publications (3)

Publication Number Publication Date
JP2007519654A JP2007519654A (ja) 2007-07-19
JP2007519654A5 true JP2007519654A5 (enExample) 2008-02-28
JP4733648B2 JP4733648B2 (ja) 2011-07-27

Family

ID=34801393

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006550004A Expired - Fee Related JP4733648B2 (ja) 2004-01-31 2005-01-18 マトリックスメタロプロテイナーゼ阻害剤としての使用のためのチエノ−イミノ酸誘導体

Country Status (5)

Country Link
US (1) US7399770B2 (enExample)
EP (1) EP1723148A2 (enExample)
JP (1) JP4733648B2 (enExample)
DE (1) DE102004004974A1 (enExample)
WO (1) WO2005073236A2 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10361075A1 (de) * 2003-12-22 2005-07-28 Pac Tech - Packaging Technologies Gmbh Verfahren und Vorichtung zur Trocknung von Schaltungssubstraten
DE102004053982B4 (de) * 2004-11-09 2011-07-21 Koop, Daniel, 25337 Verwendung von Reibhölzern und Verfahren zum Räuchern von Nahrungsmittelprodukten
DE102005015040A1 (de) * 2005-03-31 2006-10-05 Sanofi-Aventis Deutschland Gmbh Substituierte Tetrahydroisochinoline als MMP-Inhibitoren, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament
KR102074089B1 (ko) 2009-12-04 2020-02-05 선오비온 파마슈티컬스 인코포레이티드 다환형 화합물 및 이의 사용 방법
JP7187437B2 (ja) 2016-07-29 2022-12-12 サノビオン ファーマシューティカルズ インク 化合物および組成物ならびにそれらの使用
EP3490607A4 (en) 2016-07-29 2020-04-08 Sunovion Pharmaceuticals Inc. COMPOUNDS AND COMPOSITIONS, AND USES THEREOF
MX390141B (es) 2017-02-16 2025-03-20 Sunovion Pharmaceuticals Inc Metodos para tratar esquizofrenia
SG11202000669VA (en) 2017-08-02 2020-02-27 Sunovion Pharmaceuticals Inc Isochroman compounds and uses thereof
CN112135827B (zh) 2018-02-16 2024-01-12 赛诺维信制药公司 盐、晶型及其制备方法
KR20210139376A (ko) 2019-03-14 2021-11-22 선오비온 파마슈티컬스 인코포레이티드 이소크로마닐 화합물의 염, 및 이의 결정성 형태, 제조방법, 치료 용도 및 약제학적 조성물
WO2021211489A1 (en) 2020-04-14 2021-10-21 Sunovion Pharmaceuticals Inc. (s)-(4,5-dihydro-7h-thieno[2,3-c]pyran-7-yl)-n-methylmethanamine for treating neurological and psychiatric disorders

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5294621A (en) 1992-10-07 1994-03-15 Ortho Pharmaceutical Corporation Thieno tetrahydropyridines useful as class III antiarrhythmic agents
US5455258A (en) 1993-01-06 1995-10-03 Ciba-Geigy Corporation Arylsulfonamido-substituted hydroxamic acids
AU7205894A (en) 1993-06-08 1995-01-03 Neogenix, Inc. Purified natural and synthetic compounds for the treatment of osteoarthritis
US5863949A (en) 1995-03-08 1999-01-26 Pfizer Inc Arylsulfonylamino hydroxamic acid derivatives
CA2218503C (en) 1995-04-20 2001-07-24 Pfizer Inc. Arylsulfonyl hydroxamic acid derivatives
BR9611479B1 (pt) 1995-11-13 2009-01-13 Ácidos alfa-iminoidroxÂmicos e carboxÍlicos n-substituÍdos cÍclicos e heterocÍclicos.
FR2748026B1 (fr) * 1996-04-26 1998-06-05 Adir Nouveaux inhibiteurs de metalloproteases, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
DK0927183T3 (da) 1996-08-28 2004-11-29 Procter & Gamble Spirocykliske metalloprotease-inhibitorer
AU8766498A (en) * 1997-08-04 1999-02-22 Amgen, Inc. Hydroxamic acid substituted fused heterocyclic metalloproteinase inhibitors
FR2825705B1 (fr) 2001-06-08 2005-05-20 Aventis Pharma Sa Nouveaux composes heterocycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacteriens
WO2003016248A2 (en) * 2001-08-17 2003-02-27 Bristol-Myers Squibb Company Patent Department Bicyclic hydroxamates as inhibitors of matrix metalloproteinases and/or tnf-$g(a) converting enzyme (tace)
WO2003089416A1 (de) * 2002-04-22 2003-10-30 Ibfb Gmbh Substituierte pyrimidin-2,4(1h,3h)-dione als matrix metalloproteinase (mmp) inhibitoren
CN1187332C (zh) * 2002-04-26 2005-02-02 中国科学院上海有机化学研究所 四氢异喹啉羟肟酸磺酰胺类化合物、合成方法及其用途

Similar Documents

Publication Publication Date Title
JP2004516314A5 (enExample)
JP2006524222A5 (enExample)
JP2007519654A5 (enExample)
JP2011527667A5 (enExample)
JP2011037841A5 (enExample)
CA2545427A1 (en) Selective kinase inhibitors
JP2013512915A5 (enExample)
JP2009502743A5 (enExample)
AR056327A1 (es) Compuestos de nucleosidos para el tratamiento de infecciones virales
JP2016501185A5 (enExample)
JP2009542721A5 (enExample)
JP2013542996A5 (enExample)
JP2013540755A5 (enExample)
JP2013513621A5 (enExample)
JP2010536887A5 (enExample)
JP2007516180A5 (enExample)
JP2010532387A5 (enExample)
JP2013507423A5 (enExample)
JP2013514980A5 (enExample)
JP2009535307A5 (enExample)
JP2014506907A5 (enExample)
JP2010504286A5 (enExample)
JP2010504344A5 (enExample)
JP2008505117A5 (enExample)
JP2013510178A5 (enExample)